151 related articles for article (PubMed ID: 24030505)
1. Mouse models: Novel in vivo RNAi screen in mice.
Lokody I
Nat Rev Cancer; 2013 Oct; 13(10):682. PubMed ID: 24030505
[No Abstract] [Full Text] [Related]
2. Biological techniques: An embryonic view of tumour development.
Schweiger PJ; Jensen KB
Nature; 2013 Sep; 501(7466):171-2. PubMed ID: 23945591
[No Abstract] [Full Text] [Related]
3. RNAi screens in mice identify physiological regulators of oncogenic growth.
Beronja S; Janki P; Heller E; Lien WH; Keyes BE; Oshimori N; Fuchs E
Nature; 2013 Sep; 501(7466):185-90. PubMed ID: 23945586
[TBL] [Abstract][Full Text] [Related]
4. Translation from unconventional 5' start sites drives tumour initiation.
Sendoel A; Dunn JG; Rodriguez EH; Naik S; Gomez NC; Hurwitz B; Levorse J; Dill BD; Schramek D; Molina H; Weissman JS; Fuchs E
Nature; 2017 Jan; 541(7638):494-499. PubMed ID: 28077873
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Cancer Models in Zebrafish.
Casey MJ; Stewart RA
Trends Cancer; 2020 May; 6(5):407-418. PubMed ID: 32348736
[TBL] [Abstract][Full Text] [Related]
6. Modelling Cooperative Tumorigenesis in
Richardson HE; Portela M
Biomed Res Int; 2018; 2018():4258387. PubMed ID: 29693007
[TBL] [Abstract][Full Text] [Related]
7. An in vivo screening system to identify tumorigenic genes.
Ihara T; Hosokawa Y; Kumazawa K; Ishikawa K; Fujimoto J; Yamamoto M; Muramkami T; Goshima N; Ito E; Watanabe S; Semba K
Oncogene; 2017 Apr; 36(14):2023-2029. PubMed ID: 27694896
[TBL] [Abstract][Full Text] [Related]
8. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.
Pearson HB; McGlinn E; Phesse TJ; Schlüter H; Srikumar A; Gödde NJ; Woelwer CB; Ryan A; Phillips WA; Ernst M; Kaur P; Humbert P
Mol Cancer; 2015 Sep; 14():169. PubMed ID: 26376988
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs Determining Carcinogenesis by Regulating Oncogenes and Tumor Suppressor Genes During Cell Cycle.
Fasoulakis Z; Daskalakis G; Diakosavvas M; Papapanagiotou I; Theodora M; Bourazan A; Alatzidou D; Pagkalos A; Kontomanolis EN
Microrna; 2020; 9(2):82-92. PubMed ID: 31538910
[TBL] [Abstract][Full Text] [Related]
10. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
Al-Rugeebah A; Alanazi M; Parine NR
Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm.
Ahmad J; Hasnain SE; Siddiqui MA; Ahamed M; Musarrat J; Al-Khedhairy AA
Indian J Med Res; 2013 Apr; 137(4):680-94. PubMed ID: 23703335
[TBL] [Abstract][Full Text] [Related]
12. Response.
Baker SG
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766402
[No Abstract] [Full Text] [Related]
13. Loss of dynamin-related protein 1 (Drp1) does not affect epidermal development or UVB-induced apoptosis but does accelerate UVB-induced carcinogenesis.
Yanagi T; Kitamura S; Imafuku K; Suto A; Maeda T; Tanaka S; Sesaki H; Abe R; Shimizu H
J Dermatol Sci; 2020 Aug; 99(2):109-118. PubMed ID: 32636049
[TBL] [Abstract][Full Text] [Related]
14. One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?
Soto AM; Sonnenschein C
Bioessays; 2014 Jan; 36(1):118-20. PubMed ID: 24323923
[No Abstract] [Full Text] [Related]
15. Re: a cancer theory kerfuffle can lead to new lines of research.
Kaye FJ
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766401
[No Abstract] [Full Text] [Related]
16. SPAG5: An Emerging Oncogene.
He J; Green AR; Li Y; Chan SYT; Liu DX
Trends Cancer; 2020 Jul; 6(7):543-547. PubMed ID: 32291236
[TBL] [Abstract][Full Text] [Related]
17. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.
Yan R; Hallam A; Stockley PG; Boyes J
Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119
[TBL] [Abstract][Full Text] [Related]
18. CRNDE: An important oncogenic long non-coding RNA in human cancers.
Zhang J; Yin M; Peng G; Zhao Y
Cell Prolif; 2018 Jun; 51(3):e12440. PubMed ID: 29405523
[TBL] [Abstract][Full Text] [Related]
19. Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis.
Ahmad A; Ahsan H
Cancer Invest; 2020 Apr; 38(4):185-208. PubMed ID: 31971023
[TBL] [Abstract][Full Text] [Related]
20. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
